[Research progress of microvascular invasion in hepatocellular carcinoma]

Zhonghua Gan Zang Bing Za Zhi. 2022 Aug 20;30(8):899-904. doi: 10.3760/cma.j.cn501113-20210428-00211.
[Article in Chinese]

Abstract

Hepatocellular carcinoma (HCC) is a kind of highly aggressive tumor of the digestive system. Several studies have confirmed that microvascular invasion (MVI) is an independent risk factor for early recurrence and poor prognosis of HCC after surgery. Currently, pathological examination is the gold standard for diagnosing MVI. This paper summarizes concept, prognosis, preoperative prediction and treatment plan based on literature review of MVI in HCC.

肝细胞癌(HCC)是一种具有较强侵袭性的消化系统肿瘤。现有多项研究证实微血管侵犯(MVI)是HCC术后早期复发及预后不良的独立危险因素。诊断MVI的金标准为病理学检查。现从MVI概述、预后、术前预测及治疗方案进行文献综述。.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Humans
  • Liver Neoplasms* / pathology
  • Microvessels / pathology
  • Neoplasm Invasiveness / pathology
  • Prognosis
  • Retrospective Studies